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DsbA is an enzyme found in the periplasm of Gram-nega-
tive bacteria that catalyzes the formation of disulfide bonds in
a diverse array of protein substrates, many of which are
involved in bacterial pathogenesis. Although most bacteria
possess only a single essential DsbA,Neisseria meningitidis is
unusual in that it possesses three DsbAs, although the reason
for this additional redundancy is unclear. Two of these N.
meningitidis enzymes (NmDsbA1 and NmDsbA2) play an
important role in meningococcal attachment to human epi-
thelial cells, whereas NmDsbA3 is considered to have a nar-
row substrate repertoire. To begin to address the role of
DsbAs in the pathogenesis of N. meningitidis, we have deter-
mined the structure of NmDsbA3 to 2.3-A˚ resolution.
Although the sequence identity betweenNmDsbA3 and other
DsbAs is low, the NmDsbA3 structure adopted a DsbA-like
fold. Consistent with this finding, we demonstrated that
NmDsbA3 acts as a thiol-disulfide oxidoreductase in vitro
and is reoxidized by Escherichia coli DsbB (EcDsbB). How-
ever, pronounced differences in the structures between
DsbA3 and EcDsbA, which are clustered around the active
site of the enzyme, suggested a structural basis for the
unusual substrate specificity that is observed for NmDsbA3.
Neisseria meningitidis, the causative agent of epidemic men-
ingitis, is a significant public health burden worldwide causing
1.2 million cases per year globally, with an estimated fatality
rate of 10% (WHO) (1). The disease is difficult to diagnose in the
clinic because onset symptoms are similar to influenza, and
delays in the administration of antibiotics has been directly cor-
related with death of the patient, since the rapid progression of
the disease from bacteremia and/or meningitis to life threaten-
ing septic shock syndrome can occur within the first few hours
after the initial symptoms appear. Because of these parameters,
vaccination is the preferred option for the control of this disease
in the community. Meningococci express one of five capsular
serogroups (A, B, C, W-135, and Y) and successful vaccines
based upon four of these polysaccharides are available (1).
There is no vaccine candidate for serogroup B isolates as this
capsular type mimics human antigens and is therefore a poor
immunogen. As a consequence there is still considerable inter-
est in examining the pathogenic mechanisms of this organism
as this knowledge may lead to an improved understanding of
the development of infection and disease, which may provide
novel avenues to treatment.
To initiate disease, N. meningitidismust invade non-ciliated
cells of the mucosal epithelium lining the human nasopharynx,
translocate into the subepithelial tissue, and gain access to the
bloodstream (2). In this compartment, the bacteria grow tohigh
density ultimately resulting in the clinical syndrome of septic
shock (3). A diverse array of virulence factors have been impli-
cated in this process (3) including thiol-disulfide oxidoreducta-
ses of the Dsb family (4).
The Dsb family of proteins are oxidoreductases that were
initially identified in the periplasm of Gram-negative bacteria
(5–10). The family is responsible both for introducing disulfide
bonds into nascent polypeptides in the periplasm and, where
necessary, for reshuffling incorrectly formed disulfides to
enable productive protein folding. There are several members
of the Dsb family with distinct roles: DsbA catalyzes the oxida-
tion of a wide range of substrate proteins via an efficient thiol-
disulfide transfer mechanism.
Many of the DsbA substrates are involved in bacterial patho-
genesis. Reduced DsbA, which is formed in the reaction, is re-
oxidized by a membrane-bound partner, DsbB. DsbA/B form
the oxidative system that is primarily responsible for the forma-
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tion of new disulfide bonds in substrates within the periplasm.
For substrates that contain more than one pair of cysteine res-
idues, there exists the possibility that disulfides may be linked
incorrectly by DsbA, hence a second, complementary system
exists to catalyze disulfide isomerization; DsbC and its mem-
brane-bound reductive partner DsbD (Ref. 11, and references
therein).
Interestingly, most Gram-negative organisms possess only a
single DsbA and inactivation of the gene results in complete
loss of virulence. This has been ascribed to the loss of function
and increased degradation rates of misfolded substrates of
DsbA (12, 13). The Dsb system of Escherichia coli is the best
characterized and is widely used as a paradigm for the Dsb
systems of other Gram-negative bacteria. In E. coli, there is a
single DsbA enzyme (EcDsbA), which is responsible for oxida-
tion of a diverse array of protein substrates. E. coli express sev-
eral hundred potential DsbA substrates, i.e. proteins that are
predicted to enter the periplasm and contain at least one pair of
cysteine residues (14). Typically dsbA-null E. coli show reduced
levels of proteins that contain disulfides (6), including enzymes
such as alkaline phosphatase (AP)8 as well as outer membrane
flagellar motor proteins (12). The latter renders dsbA-null
E. coli non-motile.
In contrast, bioinformatic analysis suggests that N. men-
ingitidis has fewer potential DsbA substrates, but unusually,
it possesses three chromosomally encoded oxidoreductases,
NmDsbA1, NmDsbA2, and NmDsbA3. NmDsbA1 and
NmDsbA2 share 78% amino acid identity, are lipoproteins
that are anchored in the periplasmic membrane, and are
both necessary for the formation of “functional” Type IV pili
(4). NmDsbA1/NmDsbA2 double mutants express intact
pilin fibers, but are deficient in attachment to cell lines. In
addition, they have decreased transformation rates, which
has been ascribed to a reduction in the level of expression of
functional PilQ, the outer membrane porin through which
the Type IV pili are extruded (15). It has been demonstrated
that NmDsbA3, which is not membrane anchored and has 57
and 51% sequence identity with NmDsbA1 and NmDsbA2,
respectively, is unable to compensate for the loss of NmDsbA1/2.
Theability of eachof theNeisserialDsbAenzymes to complement
dsbA-null E. coli has also been tested (16). Although NmDsbA1
restored motility, NmDsbA2 and NmDsbA3 did not (16). In
contrast, EcDsbA and NmDsbA2 were able to fully restore
AP activity in dsbA-null E. coli to wild type levels, NmDsbA1
partially restored AP activity and NmDsbA3 had no effect on
AP activity (16).
These observations suggest that the meningococcal oxi-
doreductases display preferred substrate recognition patterns
and therefore are likely to be involved in multiple and distinct
processes of meningococcal pathogenesis. To begin to define
the role of theNeisserialDsbAoxidoreductases inmeningococ-
cal pathogenesis and establish the basis for separate substrate
specificities for these enzymes, we have determined the 2.3-Å
resolution structure of NmDsbA3. In addition we have deter-
mined the oxidoreductase activity of NmDsbA3 both in vitro
and in vivo. These findings suggest that NmDsbA3 functions as
a disulfide oxidase, but that differences in the active site corre-
late with its limited substrate repertoire. Collectively, these
studies suggest a structural basis for substrate specificity in the
DsbA family in N. meningitidis.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Culture Conditions
E. coli strain JM109 was used as the recipient for cloning
experiments, whereas E. coli strains JCB570 and JCB571
(kindly provided by James Bardwell, University of Michigan)
were used for complementation assays. E. coli strains were
grown aerobically in Luria-Bertani (LB) broth (1% tryptone,
0.5% yeast extract, 0.5% NaCl (w/v)) at 37 °C with shaking
(220 rpm) or on LB containing 1% agar (w/v). The growth
medium was supplemented with ampicillin (50 g/l),
chloramphenicol (30 g/l), isopropyl 1-thio--D-galacto-
pyranoside (0.3 mM), or 5-bromo-4-chloro-3-indolyl--D-
galactopyranoside (X-gal) (20 g/ml) as required.
Recombinant DNA Techniques
Unless otherwise stated recombinant standard DNA tech-
niques were used throughout (17). Plasmid extractions were
conducted using the High Pure Plasmid Isolation Kit (Roche
Applied Sciences), whereas PCR products were purified using
Qiagen PCR purification kit. Sterile H2O supplemented with 1
M Tris buffer (pH 8.0) was used in place of the commercial
elution buffer in both kits. Yield and quality of DNAwas deter-
mined by agarose gel electrophoresis.
TheN. meningitidis dsbA3 gene was amplified fromN. men-
ingitidis strain MC58 using DAP103 (5-catgccatggcgaaag-
gaaataattatgaagctc-3) and DAP104 (5-catgccatggcttgcgcttctt-
tcggatacg-3), whereas the E. coli dsbA was amplified from
E. coli strain JM109 using KAP13 (5-catgccatgggagccgacttt-
tatagaacaggc-3) and KAP14 (5-gctctagagaaataatgtccagcg-
gcaggatgc-3). The amplified fragments were cloned into the
low copy expression vector pHSG576 to create plasmids
pJKD2719 containing NmdsbA3 and pCMK255 containing
EcdsbA, respectively. The NmdsbA3, and EcdsbA genes were
excised by flanking NcoI sites from pJKD2719 and pCMK255,
respectively, and cloned into the high copy expression vector
pTrc99A to create plasmids pJKD2645 and pCMK268. Inserts
were confirmed by sequencing on an ABI Prism 3730 48 capil-
lary automatedDNA sequencer using primers KAP96 (5-agcg-
gataacaatttcacacagga-3) and KAP97 (5-gttttcccagtcacgac-3)
or DAP381 (5-gagcggataacaatttcacacagg-3) and DAP382 (5-
cgtgcacccaactgatcttcagc-3) as appropriate. Plasmids pHSG576
(18), pCMK255, and pJKD2719 were transformed into the
E. coli dsbAmutant strain JCB571 as described previously (19)
creating strains CKEC271, CKEC272, and CKEC276. Plasmids
pTrc99A, pCMK268, and pJKD2645 were transformed into the
E. coli dsbA mutant strain JCB571 creating the strains
CKEC288, CKEC289, and CKEC293, respectively.
NmDsbA3 with an N-terminal His fusion was created by SOE-
PCR. The His-enterokinase cleavage site fragment was amplified
from expression vector pET45b() (Invitrogen) using primers
8 The abbreviationsusedare: AP, alkalinephosphatase; EcDsb, Escherichia coli
Dsb; NmDsb,NeisseriameningtidisDsb; DTT, dithiothreitol; HPLC, highper-
formance liquid chromatography; LC, liquid chromatography; MS, mass
spectrometry; VcDsbA, Vibrio cholerae DsbA.
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KAP159 (5-gactcactataggggaattgtgagc-3) and KAP167 (5-
ggcatacttgtcgtcgtcatcattcgaacc-3). The NmDsbA3 gene was
amplified from NMB chromosomal DNA with primers KAP166
(5-gacaagtatgccctgacggaaggggaagac-3) and DAP269 (5-
cccaagcttggcaaacactaccgccaaaactgc-3). Primers KAP167 and
KAP166 contained complementary sequences that allowed
PCR amplification of both fragments in a second round PCR
with primers KAP161 (5-ggaattgtgagcggataacaattccc-3) and
KAP168 (5-gcaagcttctatttctgtacagcaggggtctgac-3). This PCR
fragment was then digested with HindIII and cloned into the
HindIII site of expression vector pET45b() to create the
expression vector pCMK140.
Protein Expression and Purification
EcDsbA was expressed and purified as described previously
(20). His6-tagged NmDsbA3 was expressed in BL21 C43 cells
using autoinduction (21). Briefly, cells harboring pET45b-
NmDsbA3were grownwith agitation at 200 revolutionsmin1
for 48 h at 293 K in minimal medium (21) supplemented with
ampicillin (100 g ml1). Cells were harvested by centrifuga-
tion and lysed using BugbusterTM (Novagen) according to the
manufacturers instructions. The cleared lysate was applied to a
nickel-nitrilotriacetic acid resin (GE Healthcare) and washed
with a buffer containing KH2PO4 (10 mM), NaCl (300 mM), and
imidazole (20 mM) (pH 8.0) and eluted on a gradient from 20 to
500 mM imidazole. Fractions were analyzed by SDS-PAGE and
those containing NmDsbA3 were concentrated and buffer
exchanged using an Amicon 5000 MWCO spin concentrator
(Millipore) into HEPES (10 mM) (pH 6.8). The resulting solu-
tion was applied to a cation exchange column (Mono S HR 5/5,
GE Healthcare) and NmDsbA3 eluted on a NaCl gradient
(0–250 mM) in buffer B. NmDsbA3 was chemically oxidized
(1.7 mM copper(II) phenanthroline) or reduced (10 mM dithio-
threitol). Oxidizing or reducing agents were removed by gel
filtration (Superdex 75, GE Healthcare) in Buffer C (10 mM
HEPES, pH 6.8, 150 mM NaCl).
Native NmDsbA3 protein for crystallographic studies was
expressed in E. coli BL21 DE3 Codon Plus cells (Stratagene)
transformed with pJKD2645. Cells were grown at 37 °C in
Luria-Bertani medium containing ampicillin (100 g ml1)
until an optical density at 600 nm of 0.6 was reached. Cultures
were induced by adding 1 mM isopropyl 1-thio--D-galactopy-
ranoside, grown for a further 5 h, and harvested by centrifuga-
tion. Periplasmic proteins were released by resuspending the
cell pellet in 10 mM HEPES (pH 7.8), 150 mM NaCl containing
polymyxin B sulfate (1 mg ml1) for 2 h at room temperature.
The resulting cultureswere clarified (16,000 g for 30min) and
purified chromatographically. In the first step, ammonium sul-
fate (1 M) was added to the periplasmic extract, which was fil-
tered and applied to a hydrophobic interaction column (Phenyl
HP 16/10 column (GE Healthcare). Proteins were eluted on an
ammonium sulfate gradient (1 3 0 M) in 10 mM HEPES (pH
7.8), 150 mMNaCl. Fractions were analyzed by SDS-PAGE and
those containing NmDsbA3 were pooled and diafiltered (Ami-
conUltra 5,Millipore) into 10mMHEPES (pH 6.8). The protein
was purified further usingMonoS and gel filtration as described
above. Selenomethionine-labeled NmDsbA3 was expressed
from E. coli B384 in minimal media containing selenomethio-
nine using the protocol described by Marley et al. (22). The
protein was purified as described above and concentrated to 20
mg ml1 for crystallization.
Crystallization and X-ray Diffraction Data Collection
Selenomethionine-labeled NmDsbA3 was crystallized using
the hanging-drop vapor-diffusionmethod. 1l of protein solu-
tionwasmixedwith 1l of precipitant solution (20%PEG4000,
0.1MTris, pH8.0, 0.2M sodiumacetate) and incubated at 294K.
Crystals appeared within 4 days and grew as thin plates to
dimensions 0.4 0.1 0.05mm.The crystals weremounted in
nylon loops andpassed through a solution ofmother liquor plus
20% (v/v) glycerol prior to flash-cooling in a nitrogen stream at
100K. X-ray diffraction data were collected at wavelengths cor-
responding to the peak (0.97939 Å) and inflection (0.97952 Å)
of the selenium absorption edge and at a remote wavelength
(0.97242 Å). 360° of data were collected for eachwavelengthwith
0.5°oscillationsatbeamline23ID-BGM/CAof theAdvancedPho-
ton Source, Argonne National Laboratories, from a single crystal
mounted 260 mm from a Quantum 4 CCD detector. The crystal
wasof spacegroupP21,withunit cell dimensionsa54.5b88.6
c  84.4 Å,   106.9° and diffracted to beyond 2.3 Å. The data
were processed and scaled with DENZO (23) and SCALEPACK
(23). Due to significant radiation damage to the crystal only the
peak wavelength was used for subsequent structural determina-
tion.Thedata collection statistics of thepeakwavelength are sum-
marized in Table 1.
Structure Determination and Refinement
MAD phasing was pursued as earlier attempts at molecular
replacement using related DsbA structures in the Protein Data
Bank were unsuccessful. Due to radiation damage to the crystal
the inflection and remote wavelength datasets were ignored
and a SAD phasing approach using only the peak wavelength
dataset to a maximum resolution of 3.0 Å was employed.
SOLVE (24) was used to determine the positions of the 16 sele-
nium atoms and subsequent density modification was per-
formed by RESOLVE (24). Visual inspection of the modified
electron density map revealed that each of the 4 copies of
NmDsbA3 adopted a DsbA-like fold. The four molecules of
NmDsbA3 in the asymmetric unit were arranged as a crystallo-
graphic tetramer, although there is no evidence for DsbA3 act-
ing as a physiological tetramer andmoreoverDsbA3behaved as
a monomer on gel filtration. In this crystallographic tetrameric
arrangement the catalytic cysteines at position 37werewithin 5
Å of their non-crystallographically related symmetry equiva-
lents. However, there was no continuous electron density
observed indicative of the presence of intermolecular disulfide
bonds. This is consistent with DsbA3 being in its reduced state.
MOLREP (25, 26) was thus used to place 4 copies of TcpG
(27) (PDB accession code 1BED) into the modified electron
density map. The model was improved by iterative rounds of
manual building inCOOT (28) andmaximum-likelihood based
refinement in REFMAC, with TLS (25, 29). Strict NCS
restraints were applied in the early rounds of refinement and
were subsequently loosened and then removed for the final
round of refinement. Solvent molecules were added with
COOT and checked by visual inspection of Fo Fc maps. The
Basis for Substrate Specificity inMeningococcal DsbA Enzymes
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structure was validated using the Ramachandran plot, density
fit, rotamer, and geometry analysis as implemented in COOT.
Manualmodel buildingwas continued until no peaks greater or
less than 4 were present in a Fo  Fc difference Fourier elec-
tron density map. The refinement statistics are summarized in
Table 1. The final coordinates have been deposited in the Pro-
tein Data Bank under accession code 2ZNM.
Insulin Reduction Assay
Oxidoreductase activity was measured by following the rate
of precipitation of the insulin B chain from solution in the pres-
ence of dithiothreitol (DTT) (30). Reactions were performed in
10 mM HEPES (pH 7.8), 150 mM NaCl containing 1 mM EDTA.
The reaction mixtures contained insulin (100 M) plus either
EcDsbA or His6-NmDsbA3 (5 M). The reaction was initiated
by addition of DTT (2 mM) and the rate of precipitation was
monitored from the increased turbidity of the reactionmixture,
which was measured as the absorbance at 650 nm. Absorbance
measurements were made in a 1-cm cell using a Cary50 spec-
trophotometer (Varian). The rate of insulin reduction by DTT
in the absence of DsbA was measured as a control.
Reoxidation of DsbA by EcDsbB
The reoxidation of EcDsbA and His6-NmDsbA3 by EcDsbB
was measured as previously described (31). An EcDsbB over-
producing strain, JCB851, was a kind gift from James Bardwell
(University ofMichigan). EcDsbBwas expressed and purified as
previously described (31). Oxidation of DsbA was detected by
following the time dependent change in intrinsic tryptophan
fluorescence that accompanies formation of the disulfide bond
in DsbA. EcDsbA and NmDsbA3 exhibit similar fluorescence
properties, with the reduced form of the protein having signif-
icantly higher fluorescence in each case. Fluorescence was
measured on a Cary Eclipse fluorimeter (Varian) using an exci-
tation wavelength of 295 nm and a detection wavelength of 330
nm. 5-nm slit widths were used for both excitation and emis-
sion and the temperature was maintained at 30 °C with a Pel-
tier-controlled cell holder. DsbA was reduced immediately
prior to the assay withDTT (10mM). TheDTTwas removed by
gel filtration in Buffer E (50 mM sodium phosphate, pH 8.0, 150
mM NaCl, 0.1% dodecylmaltoside containing 1 mM EDTA (to
prevent aerial oxidation of DsbA)) (Superdex 75, GE Health-
care). Reduced and oxidized EcDsbB have identical intrinsic
fluorescence (31), hence the oxidation state of EcDsbB does not
contribute to the observed changes.
Kinetics of Oxidation of Substrate Peptide
Disulfide oxidase activity was measured by following the
change in the intrinsic fluorescence of each DsbA upon oxida-
tion of a peptide substrate. The substrate peptide was derived
from the mature sequence of the meningoccol pilE2 protein.
Synthesis of the acetylated peptide Ac-C(Trt)-Q(Trt)-K(Boc)-
G-D(OtBu)-G-T(tBu)-K(Boc)-N(Trt)-Ser(tBu)-C(Trt)-RESIN,
was performed on Rink resin under standard solid phase pep-
tide synthesis conditions. Final cleavage and deprotection was
carried out using 95% (v/v) trifluoroacetic acid. The product
was recovered by a standard sequence of ether precipitation,
dissolution in 50% (v/v) aqueous acetonitrile, freeze drying fol-
lowed by HPLC purification and the peptide sequence con-
firmed by LC-MS. The kinetics of oxidation of the substrate
peptide PilE2, by His6-NmDsbA3 and EcDsbA were deter-
mined in buffer C using an Applied Photophysics SF.18MV
stopped-flow apparatus, thermostatted at 20 °C. Peptide oxida-
tionwas followed bymonitoring the change in intrinsic fluores-
cence of the DsbA variants upon reduction at wavelengths
320 nm (ex  280 nm). A 10-fold molar excess of peptide
substrate was used, such that the final concentration of the
DsbA variant and peptide were 1 and 10 M, respectively. Data
were fit to a single exponential kinetic model for substrate pep-
tide oxidation rate determination. The oxidation state of the
peptide following the reactionwithDsbAwas determinedusing
LC-MS. For comparison, samples of oxidized and reduced pep-
tide were generated via chemical oxidation with copper phe-
nanthroline (15mM) or reduction with DTT (100mM). DsbA in
buffer C was added to the reduced peptide at molar ratios
between 1:20 and 1:1 of DsbA:peptide. The mixtures were sep-
arated by reversed-phase chromatography on an Agilent 1100
HPLC using an Agilent Eclipse C18 column on a gradient from
0 to 40% acetonitrile in 0.1% formic acid over 20 min. Chro-
matographic separation was monitored by recording the total
ion current and the mass of the peptides in the resulting peaks
was analyzed using Agilent 6510 Q-TOF mass spectrometer.
Functional Analysis of DsbA Activity
DTT Sensitivity Assays—DTT assays were carried out as pre-
viously described (32). Briefly, strains were grown in LB broth
to mid-log phase, standardized to 2 108 cells/ml and diluted
101, 102, 103, and 104. Freshly prepared LB agar with and
without DTT (15 mM) was drop inoculated with each dilution
(5 l) and incubated at 37 °C for 18 h.
Motility Assays—Motility assays were performed essentially
as described (33). Briefly, strains were grown in LB broth to
mid-log phase and standardized to 2  108 cells/ml. Freshly
prepared soft LB agar (0.4%) plates were drop inoculated with
culture dilution (5 l) and swarming was observed after over-
night incubation at 37 °C.
RESULTS
Structure of NmDsbA3—To gain insight into the function of
NmDsbA3, we expressed, purified, crystallized, and deter-
mined its structure in its reduced state using the single wave-
length anomalous diffractionmethod and refined the structure
to 2.3-Å resolution to Rfactor and Rfree values of 21.0 and 26.3%,
respectively (Table 1). There are four molecules of NmDsbA3
in the asymmetric unit, all of which are highly similar (root
mean square deviation of 0.2–0.5 Å over C atoms). Accord-
ingly, one monomer in the asymmetric unit has been used
throughout for subsequent analyses. The structure revealed
thatNmDsbA3 adopted a canonical DsbA-fold (34), containing
a thioredoxin domain that contains an inserted -helical
domain (Fig. 1). The classical thioredoxin fold comprises a four-
stranded -sheet that is flanked by three -helices (35).
NmDsbA3 contains an additional -strand (1 in Fig. 1) that
precedes the N-terminal portion of the thioredoxin domain,
which is formed by residues 23–61. These residues incorporate
strand2, helix1, and strand3 ofNmDsbA3,which form the
Basis for Substrate Specificity inMeningococcal DsbA Enzymes
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 motif, including the active site CXXC sequence that is
common to all thioredoxin-like proteins. The rest of the thiore-
doxin domain is formed by residues 140–186, incorporating
the C-terminal portion of the long helix 6, strands 4 and 5,
and helix 7, which form the remaining two -helices and two
-strands in an  motif (35). This region of the protein
includes the loop containing a cis-Pro residue that is located
adjacent to the active site CXXC and is conserved in all thiore-
doxin-like proteins (Fig. 1B). The helical domain encompasses
residues 66–139 and contains four helices (2-5) plus an
extension of helix 6, which connects the helical and thiore-
doxin domains. Accordingly, the structure ofNmDsbA3 shared
a number of structural features typified by the DsbA-fold.
Comparison with EcDsbA—To gain a more detailed under-
standing of the function of NmDsbA3, we next compared the
structure to that of EcDsbA,which is themost thoroughly char-
acterized member of the DsbA family. Whereas the sequence
identity between NmDsbA3 and EcDsbA is only 24%, their
structures can be superimposed with a root mean square devi-
ation of 1.9 Å over 116 C atoms. Nevertheless, there are sev-
eral differences between the two structures that appear to be
functionally relevant. The most notable is the conformation of
the active site CXXC motif. In NmDsbA3, the Cys34-Val-His-
Cys37 motif is present on an extended loop that precedes the
1-helix (Fig. 2A). Whereas in EcDsbA, the active site is posi-
tioned at the N terminus of 1-helix, in which Cys30-Pro-His-
Cys34 form the first turn of the helix (Fig. 2B). A second critical
difference lies in the conformation of the loop that connects the
3-strand in the thioredoxin domain to the 2-helix in the hel-
ical domain (Fig. 2C). Here, a two-residue deletion in
NmDsbA3 resulted in a significant change in the conformation
of this loop. The third notable difference lay in the conforma-
tion of the loop (Fig. 2D), which connects 6-helix to the
4-strand of the thioredoxin domain and contains the con-
served cis-Pro residue. Collectively, these three regions ofDsbA
form a contiguous surface (Fig. 2E) that encompass the active
site of the thioredoxin domains (35).
FIGURE 1. Schematic representation of the structures of NmDsbA3 and
EcDsbA.A, NmDsbA3adopts a canonicalDsbA-fold comprisinga thioredoxin
domain (shown in blue) with an inserted -helical domain (shown in
magenta). The heavy atoms of the two cysteines and cis-Pro residue that form
the conserved active site residues of the thioredoxin domain are shown as
spheres. B, EcDsbA in the same orientation (Protein data bank code 1FVK;
chain B). The heavy atoms of Cys30, Cys33, and cis-Pro151 in the active site are
shown as spheres.
FIGURE 2. Comparison of the structure of active site loops in NmDsbA3
and EcDsbA. A, in NmDsbA3 the active site Cys34-Val-His-Cys37 forms an
extended loop. B, the active site Cys30-Pro-His-Cys33 of EcDsbA forms the first
turnof helix1 in the thioredoxindomain.C andD, superpositionof the loops
connecting the thioredoxin and helical domains of NmDsbA3 and EcDsbA.
Residues are colored as described in the legend to Fig. 1. Key amino acid
residues are shown in stick representation and labeled. E, these regions of the
structure form a contiguous surface that surrounds the active site of DsbA.
TABLE 1
X-ray data collection and processing statistics
Values in parentheses represent those of the highest resolution shell 2.38-2.30 Å.
Space group P21
Cell dimensions (Å) a 54.5 b 88.5 c 84.3,  106.9°
Resolution (Å) 50-2.3
Rsyma 4.8 (27.8)
I/I 43.3 (5.0)
Completeness (%) 94 (65)
Redundancy 5.2
Refinement
Resolution (Å) 30-2.3
Reflections in working set 34,110
Rfactorb 0.210
Rfreeb 0.263
Total residues
A chain 3–187
B chain 3–187
C chain 3–188
D chain 3–186
Total protein atoms 5,863
Total waters 176
Bond lengths (Å) 0.009
Bond angles (°) 1.197
Ramachandran analysis
Most favored (%) 91.8
Additionally allowed (%) 8.2
Average B factor (Å2) 58.5
aRsymhl Ihl I(h)	/hlIh	, where Ihl is the lth observation of reflection h and
Ih	 is the weighted average intensity for all observations l of reflection h.
b Rfactor  hklFo  Fc/hklFo for all data excluding the 5% that comprised the
Rfree used for cross-validation.
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In the helical domain ofNmDsbA3, the loop between the3-
and 4-helices contains an additional four residues, which
causes a displacement of helix 4 and helix 5 relative to
EcDsbA (Fig. 3, A and B). Notwithstanding this difference, the
topology of the helical domains of NmDsbA3 and EcDsbA is
conserved between the two structures.
Finally, the loop linking the 5-strand to the 7-helix of the
thioredoxin domain of NmDsbA3 is four residues shorter than
in EcDsbA, which results in helix 7 having one less turn of
helix inNmDsbA3 (Fig. 3,C andD). This helix forms part of the
hydrophobic groove below the active site inDsbA enzymes that
is the binding site for EcDsbB (36). Comparison of the electro-
static surfaces of NmDsbA3 and EcDsbA (Fig. 4) revealed that
NmDsbA3 retained the conserved hydrophobic features of the
DsbB-binding site that have previously been observed in DsbA
enzymes of Gram-negative bacteria (37).
In the structures of both EcDsbA and Vibrio cholerae DsbA
(VcDsbA) (27, 34), there is a conserved acidic patch that is
located on the face of the enzyme opposite the active site.
Although no functional role has been ascribed to this region of
the structure of DsbA, its conservation has led to the proposal
that it may be functionally important (27). In NmDsbA3, there
are no corresponding acidic residues in this region of the struc-
ture, and indeed NmDsbA3 is slightly basic in this region. The
functional significance of this difference remains unresolved.
Accordingly, whereas NmDsbA3 is similar to EcDsbA, there
are a number of notable structural differences in the vicinity of
the thioredoxin active site.
Disulfide Reductase Activity—Given that NmDsbA3 pos-
sessed a DsbA-fold, yet possessed unique features around the
active site, we next tested the functional activity of NmDsbA3.
The oxidoreductase activity of NmDsbA3 was characterized in
vitro, first by determining its ability to reduce insulin. The insu-
lin reduction assay follows precipitation of the insulin B-chain,
which results from reduction of the interchain disulfide. The
activity of NmDsbA3 was measured and compared with
EcDsbA (Fig. 5A). Each increased the rate of precipitation
over that caused by DTT alone in the absence of enzyme. The
lag time to the appearance of measurable precipitate for
NmDsbA3 was significantly longer than that observed for
EcDsbA and the rate of precipitation was approximately
halved. These observations are consistent with NmDsbA3
acting as a DsbA-like oxidase.
FIGURE 3.Differences in the structures of NmDsbA3 and EcDsbA. A and B,
helix 7, which forms a part of the hydrophobic groove that in EcDsbA is the
binding site for EcDsbB, is shortened in NmDsbA3 by four residues. C and D,
the helical domains of NmDsbA3 and EcDsbA exhibit identical topologies,
although insertions and deletions in the loops between the helices result in
displacement of their positions in the two structures.
FIGURE 4. Electrostatic surfaces of NmDsbA3 and EcDsbA. Several of the
hydrophobic surface features that surround the active site of EcDsbA (B) are
conserved in NmDsbA3 (A). The hydrophobic groove in EcDsbA has been
demonstrated as the site of interactionwithDsbB. An acidic patch of residues
that is present in EcDsbA (D) is absent in NmDsbA3 (C).
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Disulfide Oxidase Activity—Next, the disulfide oxidase activ-
itywas determined in vitro bymeasuring the rate of oxidation of
a model substrate peptide. The sequence around the two cys-
teines in the major subunit of type IV Neisserial pili (PilE) was
synthesized and used as amodel substrate peptide. The kinetics
of oxidation of the peptide by EcDsbA and NmDsbA3 were
monitored by stopped-flow fluorescence. In each case the
intrinsic fluorescence of the reduced form of DsbA was signif-
icantly higher than that of oxidized DsbA. In the course of the
assay, oxidation of the peptide substrate resulted in concomi-
tant reduction of the DsbA enzyme, which led to an increase in
fluorescence. A 10-fold excess of peptide was used in the assay.
The reactions showed first-order kinetics and the rate of oxida-
tion of the PilE peptide substrate was somewhat slower in the
case of EcDsbA (k  0.11 s1) than NmDsbA3 (k  2.0 s1)
(Fig. 5, C and D). The peptide species generated by reaction
with NmDsbA3 was analyzed by LC-MS (Fig. 6). This analysis
revealed the reaction with NmDsbA3 generated a peptide
with a shorter retention time on C18 reversed phase HPLC,
which was 2 mass units lighter than the reduced peptide,
consistent with formation of a disulfide bond in the reduced
PilE2 peptide upon reaction with NmDsbA3. The oxidation
of the peptide by NmDsbA3 was essentially quantitative.
These data indicate that NmDsbA3 is capable of acting as a
disulfide oxidase in vitro.
Reoxidation by EcDsbB—Next, the in vitro oxidation of
reduced NmDsbA3 by E. coli EcDsbB was measured by record-
ing the decrease in intrinsic fluorescence that accompanies oxi-
FIGURE 5. In vitro activity of NmDsbA3. A, disulfide reductase activity of
NmDsbA3 was determined using the insulin reduction assay in the absence
(f) and presence of () EcDsbA (1 M) or (Œ) NmDsbA3 (1 M). Both EcDsbA
andNmDsbA3catalyze the reductionof insulinbyDTT.B, the ability of EcDsbB
to reoxidize reduced DsbA was measured by following the decrease in intrinsic
fluorescence that accompanies oxidation of EcDsbA and NmDsbA3. Progress
curves are shown for the reoxidationof EcDsbA (50M) (f) andNmDsbA3 (50
M) (Œ) by EcDsbB (80 nM). In the absence of EcDsbB there is no change in
fluorescence for either EcDsbA () or NmDsbA3 (data not shown). Both
EcDsbA and NmDsbA3 are substrates for EcDsbB and are reoxidized at a sim-
ilar rate.C andD, disulfide oxidase activitywas determinedbymonitoring the
oxidation of a model peptide substrate derived from the Neisserial pilin sub-
unit PilE. The kinetics of the oxidation reactions were determined using
stopped-flow fluorescence by monitoring the increase in fluorescence upon
reduction of DsbA in the assay. Both EcDsbA and NmDsbA3 catalyze the oxi-
dation of the PilE peptide, with NmDsbA3 being the more efficient catal.
FIGURE 6. HPLC-MS analysis of substrate peptide. Chemically reduced (A)
and oxidized (B) PilE2 peptide gave peaks with m/z 1181 and 1179, respec-
tively, consistent with the presence of two free thiol groups in the reduced
peptide andadisulfide in theoxidizedpeptide.C, additionofNmDsbA3 (1:20)
to reduced PilE2 peptide resulted in the appearance of an earlier eluting peak
in the chromatogram. D, analysis revealed that the new peak contained a
species havingm/z of 1179, indicating that reaction with NmDsbA3 resulted
in formation of a disulfide in the PilE2 peptide.
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dation of DsbA. This assay revealed that NmDsbA3 is a sub-
strate for EcDsbB (Fig. 5B). The rates of oxidation of NmDsbA3
and EcDsbA in this assay were similar, suggesting that
NmDsbA3 is a substrate for EcDsbB and may be reoxidized by
EcDsbB in vivo.
Functional Studies—We then wished to explore further the
functional role of NmDsbA3 in vivo. The E. coli dsbA mutant
strain JCB571 is sensitive to DTT and is not motile on soft agar
due to a disulfide bond deficiency in FlgI, a component of the
flagellum motor. The ability of NmDsbA3 to complement
JCB571 resistance to DTT and motility was assessed. Previ-
ously, complementation studies have been reported for JCB571
transformed with a vector containing NmdsbA3 in pGEM-T
(16). The transformed cells were demonstrated to express
NmDsbA3 to the periplasm. The level of expression of
NmDsbA3 was similar to that of EcDsbA expressed from the
same vector, but whereas EcDsbA complemented JCB571,
expression of NmDsbA3 had no effect on either motility or
DTT resistance (16). We observed similar results in JCB571
when NmDsbA3 and EcDsbA were expressed from the low
expression vector pHSG576. To determine whether higher
expression levels of NmDsbA3 would result in complementa-
tion of JCB571, NmDsbA3was expressed from the high expres-
sion vector pTrc99A. Expression of NmDsbA3 from a high
copy vector in the transformed JCB571 strain CKEC293 con-
ferred resistance toDTT (15mM) andmotilility on 0.4%LB agar
similar to the positive control strain CKEC289 expressing the
EcDsbA and wild-type strain JCB570 (Fig. 7, A and B). Similar
results for CKEC293 were obtained when assays were repeated
in the presence of isopropyl 1-thio--D-galactopyranoside
(data not shown). Thus, NmDsbA3 also functions as an oxi-
doreductase in vivo, albeit with an apparently reduced activity
in comparison to EcDsbA.
DISCUSSION
It has previously been demonstrated that N. meningitidis
expressing NmDsbA3 in the absence of NmDsbA1 and
NmDsbA2 are sensitive to DTT and do not express functional
pili (4). Furthermore, NmDsbA3 was previously found to be
unable to complement the non-motile phenotype of dsbA-null
E. coli (16). From these findings it has been inferred that
NmDsbA3 has a limited repertoire and does not oxidize a wide
range of substrate proteins found in the periplasm ofN. menin-
gitidis and E. coli.
To begin to address the apparent atypical function of
NmDsbA3, we determined its structure and undertook a series
of functional studies. The structure revealed that NmDsbA3
possessed aDsbA-like fold, and displayed oxidoreductase activ-
ities typical of the DsbA family. Interestingly, the structure of
NmDsbA3 revealed a number of distinct features that may be
critical in dictating the observed activity of the enzyme. Several
of the differences between the structure of NmDsbA3 and
EcDsbA are found in the key loops that surround the active site
of the enzyme. These include the first loop connecting the thi-
oredoxin and helical domains as well as the cis-Pro loop. Nota-
blyNmDsbA1 andNmDsbA2, which share 78% sequence iden-
tity, have been demonstrated to have different activities in vivo,
but have divergent sequences in both of these loops. It has pre-
viously been demonstrated thatmutations in the cis-Pro loop of
DsbC and DsbG can affect the substrate specificity of these
enzymes (38). Thus, it is possible that the sequence of the cis-
Pro loop is critical in dictating the substrate repertoire of Dsb
enzymes. To illustrate, most Gram-negative DsbA enzymes
have a Val residue preceding the cis-Pro that is located adjacent
to the active site. Although the structure of NmDsbA3 retains
the cis-Pro, the residue preceding it is Thr. A similar motif
(Thr-cis-Pro) is highly conserved in Gram-negative disulfide
isomerases (DsbC andDsbG). The Thr-cis-Pro sequence that is
present in NmDsbA3 raises the question of whether it acts as
oxidase or isomerase. Our in vitro measurements of the oxi-
doreductase activity of NmDsbA3 suggests that it is an oxidase
rather than an isomerase. A Thr-cis-Pro sequence has previ-
ously been reported in the Gram-positive DsbA from Staphylo-
coccus aureus (SaDsbA), which is also a disulfide oxidase in
vivo. There are a number of differences between SaDsbA and
the DsbA enzymes of Gram-negative bacteria, notably that the
disulfide bond does not destabilize the oxidized form of the
protein (39) in contrast to EcDsbA (40) andVcDsbA (41), and S.
aureus does not possess a DsbB ortholog, suggesting that it is
oxidized by a different mechanism to that observed in Gram-
negative bacteria. Notwithstanding these differences, SaDsbA
displays in vitro activity that is reminiscent of an oxidase rather
than an isomerase (39). Furthermore, both NmDsbA1 and
NmDsbA2, each of which are capable of partially complement-
ing dsbA-null E. coli (4, 16), and therefore most likely act as
oxidase enzymes in vivo retain the Thr-cis-Pro motif that is
present in NmDsbA3. This is consistent with the view that the
sequence of the cis-Pro loop is critical in determining substrate
FIGURE7.Complementationassays.A and B, wild type E. coli JCB570 (lane 1)
were able togrow in thepresenceofDTT (15mM),whereas the corresponding
dsbA-null strain JCB571 (lane 2) were not. Expression of EcDsbA (lane 3) or
NmDsbA3 (lane 4) from the high copy expression plasmid ptrc99A restored
resistance toDTT in JCB571.C, expressionof EcDsbA from the lowcopyvector
pHSG576 restored motility to JCB571 (zone 1). In contrast, expression of
NmDsbA3 frompHSG576 (zone 3) did not restoremotility. JCB571 containing
the empty expression vector (zone 2)was non-motile.D,motilitywas restored
to JCB571when EcDsbA (zone 2) andNmDsbA3 (zone 4) were expressed from
the high copy expression vector, ptrc99A. JCB571 containing the empty
pTrc99Awas non-motile (zone 3). JCB570 is a motile positive control (zone 1).
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specificity, but does not necessarily dictate the oxidase or
isomerase activity of the enzyme (38, 39).
Despite the differences in the loop sequences that surround
the active site, a number of the conserved surface features that
have been observed in other DsbA enzymes (37) also appear to
be present in NmDsbA3. Both the hydrophobic patch (Fig. 4)
and the hydrophobic groove adjacent to the active site are con-
served in the structure of NmDsbA3. The hydrophobic groove,
which forms the binding site in EcDsbA for EcDsbB, is short-
ened inNmDsbA3. There are similar deletions in both VcDsbA
and SaDsbA, which also result in a shortening of helix7. How-
ever, the electrostatic surfaces of the proteins are quite differ-
ent. In EcDsbA, VcDsbA, and NmDsbA, the groove has a
hydrophobic surface, whereas in SaDsbA the groove is charged
(39). We have determined that NmDsbA3 is re-oxidized by
EcDsbB in vitro and at a similar rate to EcDsbA. Furthermore,
because VcDsbA complements themotility of dsbA-null E. coli,
it is also presumed to be a substrate for EcDsbB. In contrast, it
has been shown the SaDsbA is not a substrate for EcDsbB (39).
Thus it appears that the nature of the surface, rather than the
length of helix 7 per se is the important determinant of spec-
ificity for EcDsbB.
However, these differences in the nature of the groove can-
not fully explain the observed activities of the different DsbA
enzymes. For example, SaDsbA appears to be more like
EcDsbA, in that it can complement dsbA-null E. coli and is
capable of restoring the motility, whereas NmDsbA3 can only
do so when it is strongly overexpressed. In contrast, NmDsbA3
and EcDsbA show similar activity toward EcDsbB and both are
capable of catalyzing the reduction of insulin, whereas SaDsbA
is not reoxidized by EcDsbB and does not catalyze insulin
reduction (39, 42). Finally, dsbA-null E. coli display pleiotropic
phenotypes associated with a deficiency in oxidative protein
folding (5, 6, 12), whereas, deletion of either SadsbA or
NmdsbA3 from their respective hosts does not produce any
measurable phenotype either in vitro or in vivo (4, 16, 42).
Taken together, these observations suggest that NmDsbA3 and
SaDsbA have a narrower substrate repertoire than EcDsbA.
Furthermore, they indicate that disulfide oxidase activity can be
maintained in DsbA enzymes that are not substrates for
EcDsbB, which may indicate that the processes by which oxi-
dized DsbA recognizes its substrates are subtly different from
those that dictate the interation of reduced DsbA with DsbB.
The structures of NmDsbA3 and SaDsbA provide a rationale
for these observations. Despite retaining a similar fold to
EcDsbA, there are a number of critical differences between the
structures of different DsbA enzymes. The hydrophobic
groove, which is absent in SaDsbA appears to be essential for
interaction with EcDsbB. In contrast, the hydrophobic groove
is not an absolute requirement for oxidase activity, but changes
in the composition and conformation of the surface loops that
surround the active site appear to regulate interactionwith sub-
strates. One of these loops contains the conserved cis-Pro resi-
due that is common to all thioredoxin-like proteins and has
previously been shown to regulate substrate specificity in disul-
fide isomerases DsbC and DsbG (38). Taken together these
findings suggest that this may be a common mechanism for
regulating the specificity of thioredoxin-fold oxidoreductases.
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